The Optimal Health Manifesto
6 min read ·

Everyone pairs NAD+ with 5-Amino-1MQ. Should you

By Rick Gold

If you have looked at a longevity stack lately, you have seen the NAD+ and 5-Amino-1MQ pairing in it, and the evidence behind the two compounds is very uneven. Short answer: in NAD+ vs 5-Amino-1MQ, NAD+ (or its oral precursors) has human trial data and 5-Amino-1MQ has rat data only, so most people should start with NAD+ and treat 5-Amino-1MQ as an optional add-on for a specific profile.

What each one actually does

NAD+ is a coenzyme your mitochondria use to turn food into energy, and the fuel for sirtuins and DNA-repair enzymes. It falls with age, and restoring it is the whole premise of supplementing it. It is a coenzyme and sits in the same catalog and the same conversations as the peptides.

5-Amino-1MQ is a small oral molecule that inhibits NNMT, an enzyme that methylates nicotinamide (a recycled NAD+ byproduct) and removes it from the salvage pathway. Blocking NNMT keeps more nicotinamide available for recycling into NAD+. If NAD+ is already very low, that recycling has little material to work with.

There is a second pathway that lowers NAD+: CD38, an enzyme that rises with age and inflammation and consumes NAD+ directly. In mice that lacked CD38, NAD+ stayed at youthful levels across their lifespan. That is animal work, but it is why inhibiting only NNMT while CD38 keeps consuming NAD+ tends to underwhelm.

Evidence quality

This is where the two diverge most. For the oral precursors, NR raised blood NAD+ by 22%, 51% and 142% at 100, 300 and 1000 mg, a clean dose response. NMN at 250 mg a day improved muscle insulin sensitivity in prediabetic postmenopausal women. Functional benefits are population-specific, and healthy people often show a biochemical change without a dramatic result, but the base is real.

Injectable NAD+ is a different tier. Clinics use it widely and users report better energy and clarity, but controlled efficacy trials for the injectable route are still being built. I treat it as strong real-world use with thin formal data.

5-Amino-1MQ has one published pharmacokinetic study, in rats, showing about 38% oral bioavailability and a half-life near 7 hours. Nobody has published human pharmacokinetics or a human efficacy trial. The dramatic fat-loss numbers come from diet-induced obese mice, which had abnormally high NNMT to begin with. If a vendor quotes you a human bioavailability figure for it, that is marketing. I wrote about the fatigue claims separately in 5-Amino-1MQ for fatigue and energy.

Cost and side-effect load

Oral NR or NMN runs roughly $60 to $90 a month, subcutaneous NAD+ roughly $150 to $250 a month, and IV sessions $500 to $1,000 each. 5-Amino-1MQ is a capsule or liquid, usually a 50 mg vial from a vendor, and you need to budget for it on top of the NAD+ because it only makes sense alongside a substrate.

Side effects differ in kind. NAD+ injected quickly causes chest pressure, a racing heart, flushing and nausea, and the fix is speed: slower delivery or smaller subcutaneous doses make most of it disappear. Subcutaneous NAD+ also leaves a small itchy welt for an hour or two because the solution is acidic. Oral precursors are well tolerated, though starting too high can leave you jittery and sleeping badly.

5-Amino-1MQ is lighter day to day, with occasional GI upset and some shifts in how you feel from the methylation changes. Its real concern is theoretical: with too little NAD+ substrate and high CD38, salvaged NAD could be shunted toward senescent and cancer cells. That mechanism has not been confirmed in primary literature, but it is the reason I never suggest running it solo, and why active cancer, pregnancy and breastfeeding are hard exclusions for both compounds.

Who each one suits

NAD+ suits almost anyone who wants to address the age-related decline, and the route follows your budget and tolerance. Oral NR or NMN is the trial-backed daily option, subcutaneous is the middle ground, and IV is for severe deficit states. One caution: people with burnout or dysregulated stress physiology can feel worse when they push energy production harder, so start low.

5-Amino-1MQ suits a narrower group. NNMT overexpression tracks with body fat, so someone with excess weight, insulin resistance or metabolic dysfunction matches the mechanism. A lean, healthy person trying to optimize longevity is usually better served by putting the money into direct NAD+ precursors. Daily exercise also suppresses NNMT on its own and raises NAMPT, the rate-limiting enzyme of the salvage pathway, by about 127% after three weeks of training in sedentary adults, so if you already train hard, there is less for the inhibitor to do. I see this with clients regularly: the person asking about the third compound in the stack has not yet fixed sleep or training.

Protocols people actually run

Studies used 300 to 1000 mg a day of NR and 250 mg a day of NMN. For subcutaneous NAD+, the common practitioner schedule is 25 mg twice a week for two weeks, 50 mg twice a week for two weeks, then 100 mg twice a week through about week 8, followed by roughly 100 mg weekly or every other week. Many cycle three months on and one month off, a clinician convention that no confirmed mechanism explains.

For 5-Amino-1MQ, most users run 50 to 100 mg a day orally, taken in the morning, for 60 days, then take at least 30 days off and restart at the same dose. Microdoses of 150 to 600 mcg a day are far below any plausible enzyme-inhibiting concentration, so I would skip those. If you want the pair, run NAD+ continuously and let only the 5-Amino-1MQ cycle.

Disclaimer:

The doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

If you decide to buy, note that OHM has an affiliate relationship with the vendors linked here, so we earn a commission if you buy through one of these links. It costs you nothing extra.

My recommendation is to run NAD+ alone for a couple of months, add consistent training, and only bring in 5-Amino-1MQ if your body composition and metabolic markers match the profile above.

Thanks for reading! In health, Rick Gold

Frequently asked questions

Do I need 5-Amino-1MQ if I already take NAD+?

Probably not if you are lean and metabolically healthy. 5-Amino-1MQ blocks an enzyme (NNMT) that is mostly overexpressed in excess body fat, so a lean person has little to correct. Direct NAD+ or oral NR/NMN covers the supply side with far better evidence.

Which has better human evidence, NAD+ or 5-Amino-1MQ?

NAD+ and its oral precursors have dozens of human trials showing they raise blood NAD+. 5-Amino-1MQ has one published rat pharmacokinetic study and no human data. The gap is large.

How long should I run 5-Amino-1MQ?

The community convention is 60 days on and at least 30 days off, restarting at the same dose. Users report a plateau after about 60 days, and raising the dose does not fix it.

Can 5-Amino-1MQ be run alone?

Most practitioners say no. Without an NAD+ substrate to protect, blocking NNMT has little to work with, and a reported concern is that salvaged NAD could be shunted toward CD38-high cells. Anyone with active cancer should avoid it.